J2h Biotech

This early-phase study tested a single dose of the experimental drug J2H-1702 in 16 healthy women aged 19 to 45. The main goal was to check safety and how the drug moves through the body. This is a first step toward possibly treating non-alcoholic steatohepatitis (NASH), a seriou…